🦠 HPV Genital Warts Treatment Simulator

Baseline Wart Lesion Cluster

Genital warts form soft clustered papules from HPV infection.

• 6, 11: Common HPV types (low-risk strains)
• 3wk–8mo: Incubation range (variable onset)
• 1–10: Typical lesion count (per patient)
• ~30%: Spontaneous clearance (untreated cases)

Lesion appearance

Placeholder: soft flesh-colored papules cluster near mucosal surfaces.

Placeholder insight: early treatment shortens total clearance time.

Diagnosis basis

Placeholder: clinical visual exam confirms most condyloma cases.

Liquid Nitrogen Freeze Mechanism

Cryotherapy freezes lesion cells causing rapid necrosis.

• −196°C: Freeze temp (liquid nitrogen)
• 3–6: Sessions typical (biweekly visits)
• ~75–88%: Clearance rate (multi-session)
• ~35%: Recurrence (reported range)

Freeze-thaw cycle

Placeholder: freezing bursts cell membranes via ice crystal formation.

Placeholder insight: repeat sessions needed for full clearance.

Recovery

Placeholder: blistering and mild pain follow each treatment.

Topical Immune-Response Activation

Imiquimod cream recruits immune cells to clear lesions.

• TLR7: Mechanism (agonist pathway)
• 3x/wk: Application (up to 16 weeks)
• ~50–75%: Clearance rate (gradual course)
• ~15%: Recurrence (lowest among options)

Immune activation

Placeholder: local cytokines summon immune cells to lesion sites.

Placeholder insight: slower onset but lowest recurrence rate.

Patient-applied

Placeholder: self-administered cream over several weeks at home.

Podophyllotoxin & TCA Mechanisms

Chemical agents destroy wart tissue via cytotoxic or acid action.

• Cytotoxic: Podophyllotoxin (antimitotic agent)
• 80–90%: TCA strength (acid concentration)
• ~80–85%: Clearance rate (fast onset)
• ~36–38%: Recurrence (reported range)

Podophyllotoxin action

Placeholder: halts cell division, causing lesion tissue death.

Placeholder insight: fast visible response within days.

TCA action

Placeholder: acid coagulates proteins, chemically burning lesions.

Clearance Speed & Recurrence Compared

All four methods differ in speed, clearance ceiling, and recurrence.

• TCA: Fastest onset (chemical burn)
• Imiquimod: Lowest recurrence (immune-based)
• Cryotherapy: Most sessions (clinic visits)
• Cryotherapy: Highest ceiling (~88% cleared)

Choosing a method

Placeholder: choice balances speed, cost, and recurrence tolerance.

Placeholder insight: combination therapy may reduce recurrence further.

Follow-up care

Placeholder: monitoring after clearance detects early recurrence.